Allscripts revenues surge in Q1

Healthcare software and services provider Allscripts-Misys Healthcare Solutions saw revenues surge to $164.9 million in its fiscal first quarter (ending Aug. 31), up from $92.8 million reported in the same period a year ago.

The Chicago-based company, which formed last year after a unit of Allscripts merged into Misys, reported first quarter earnings of $12.9 million, more than doubling its earnings in the same period last year. The company reported a gross margin of 54 percent for the first quarter, compared with 53.9 percent for the same quarter a year ago.

Glen Tullman, CEO of Allscripts, credited the company’s “solid results” to a “successful merger, a focused effort on the processes critical to our growth, and great execution by our team. We're seeing strong demand for our products, even in advance of the federal stimulus incentives that we expect will accelerate adoption as we work towards our vision of transforming healthcare into a connected system of health."

Michael Bassett,

Contributor

Around the web

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Trimed Popup
Trimed Popup